Active ingredients: buprenorphine
What it is used for
TEMGESIC Injection is indicated for the short-term (not more than one week) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. TEMGESIC Injection should be employed when sublingual administration is not practical e.g. pre- or peri-operatively. TEMGESIC is not recommended for use in children. TEMGESIC does not have an approved role in opioid dependence rehabilitation programmes.
How to take it
The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear colourless solution
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems